Genetics of Attention Deficit Hyperactivity Disorder

Child and Adolescent Psychiatric Clinics of North America

Volumn 17, Issue 2, 2008, Pages 261-284

  Mick, Eric ^a   Faraone, Stephen V ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1C ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CHOLINERGIC RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; GLUTAMATE RECEPTOR; NICOTINIC RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SYNAPTOSOMAL ASSOCIATED PROTEIN 23; TRYPTOPHAN HYDROXYLASE;

ATTENTION DEFICIT DISORDER; GENE ACTIVITY; GENETIC VARIABILITY; GENOME; HUMAN; MOLECULAR GENETICS; NEUROBIOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADOPTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; DISEASES IN TWINS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RECEPTORS, NEUROTRANSMITTER;

EID: 39449133654     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2007.11.011     Document Type: Review

References (157)

1. Faraone S.V., Sergeant J., Gillberg C., et al. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2 2 (2003) 104-113
2. Kessler R.C., Adler L., Barkley R., et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 163 4 (2006) 716-723
3. Faraone S.V., and Biederman J. Nature, nurture, and attention deficit hyperactivity disorder. Dev Rev 20 (2000) 568-581
4. Faraone S.V., Perlis R.H., Doyle A.E., et al. Molecular genetics of attention deficit hyperactivity disorder. Biol Psychiatry 57 11 (2005) 1313-1323
5. Sprich S., Biederman J., Crawford M.H., et al. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 39 11 (2000) 1432-1437
6. Cantwell D.P. Genetics of hyperactivity. J Child Psychol Psychiatry 16 (1975) 261-264
7. Morrison J.R., and Stewart M.A. The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 28 June (1973) 888-891
8. Fisher S.E., Francks C., McCracken J.T., et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70 5 (2002) 1183-1196
9. Smalley S.L., Kustanovich V., Minassian S.L., et al. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 71 4 (2002) 959-963
10. Bakker S.C., van der Meulen E.M., Buitelaar J.K., et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 72 5 (2003) 1251-1260
11. Arcos-Burgos M., Castellanos F.X., Konecki D., et al. Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate. Mol Psychiatry 9 3 (2004) 252-259
12. Ogdie M.N., Bakker S.C., Fisher S.E., et al. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol Psychiatry 11 1 (2006) 5-8
13. Hebebrand J., Dempfle A., Saar K., et al. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 german sib-pairs. Mol Psychiatry 11 2 (2006) 196-205
14. Lander E., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995) 241-247
15. Li D., Sham P.C., Owen M.J., et al. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15 4 (2006) 2276-2284
16. Yang B., Chan R.C., Jing J., et al. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B 4 (2007) 541-550
17. Purper-Ouakil D., Wohl M., Mouren M.C., et al. Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 15 1 (2005) 53-59
18. Cheuk D.K., and Wong V. Meta-analysis of association between a Catechol-O-Methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 36 (2006) 651-659
19. Lanau F., Zenner M., Civelli O., et al. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 68 2 (1997) 804-812
20. Faraone S.V., and Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44 10 (1998) 951-958
21. Van Tol H.H., Wu C.M., Guan H.C., et al. Multiple dopamine D4 receptor variants in the human population. Nature 358 6382 (1992) 149-152
22. Asghari V., Sanyal S., Buchwaldt S., et al. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65 3 (1995) 1157-1165
23. El-Faddagh M., Laucht M., Maras A., et al. Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age. J Neural Transm 111 7 (2004) 883-889
24. Bhaduri N., Sinha S., Chattopadhyay A., et al. Analysis of polymorphisms in the dopamine Beta hydroxylase gene: association with attention deficit hyperactivity disorder in Indian children. Indian Pediatr 42 2 (2005) 123-129
25. Kim Y.S., Leventhal B.L., Kim S.J., et al. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Neurosci Lett 390 3 (2005) 176-181
26. Carrasco X., Rothhammer P., Moraga M., et al. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am J Med Genet B Neuropsychiatr Genet 141 1 (2006) 51-54
27. McCracken J.T., Smalley S.L., McGough J.J., et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5 5 (2000) 531-536
28. Kustanovich V., Ishii J., Crawford L., et al. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry 9 (2004) 711-717
29. Barr C.L., Feng Y., Wigg K.G., et al. 5′-untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 105 1 (2001) 84-90
30. Todd R.D., Neuman R.J., Lobos E.A., et al. Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. Am J Med Genet 105 5 (2001) 432-438
31. Brookes K.J., Xu X., Chen C.K., et al. No evidence for the association of DRD4 with ADHD in a Taiwanese population within-family study. BMC Med Genet 6 (2005) 31
32. Bhaduri N., Das M., Sinha S., et al. Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. Am J Med Genet B Neuropsychiatr Genet 141B 1 (2006) 61-66
33. Lowe N., Kirley A., Mullins C., et al. Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with the SNP-616. Am J Med Genet 131B 1 (2004) 33-37
34. Brookes K., Xu X., Chen W., et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11 (2006) 934-953
35. Rowe D.C., Stever C., Chase D., et al. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry 6 4 (2001) 429-433
36. Levitan R.D., Masellis M., Lam R.W., et al. Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology 29 1 (2004) 179-186
37. Todd R.D., Huang H., Smalley S.L., et al. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. J Child Psychol Psychiatry 46 10 (2005) 1067-1073
38. Mill J., Xu X., Ronald A., et al. Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am J Med Genet B Neuropsychiatr Genet 133B 1 (2005) 68-73
39. Kieling C., Roman T., Doyle A.E., et al. Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry 60 (2006) 1163-1165
40. Swanson J., Oosterlaan J., Murias M., et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci USA 97 9 (2000) 4754-4759
41. Manor I., Tyano S., Eisenberg J., et al. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry 7 7 (2002) 790-794
42. Bellgrove M.A., Hawi Z., Lowe N., et al. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet B Neuropsychiatr Genet 136 1 (2005) 81-86
43. Langley K., Marshall L., van den Bree M., et al. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 161 1 (2004) 133-138
44. Grady D.L., Harxhi A., Smith M., et al. Sequence variants of the DRD4 gene in autism: further evidence that rare DRD4 7R haplotypes are ADHD specific. Am J Med Genet B Neuropsychiatr Genet 136 1 (2005) 33-35
45. Lynn D.E., Lubke G., Yang M., et al. Temperament and character profiles and the dopamine D4 receptor gene in ADHD. Am J Psychiatry 162 5 (2005) 906-913
46. Hawi Z., Lowe N., Kirley A., et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8 3 (2003) 299-308
47. Lowe N., Kirley A., Hawi Z., et al. Joint analysis of DRD5 marker concludes association with ADHD confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 74 2 (2004) 348-356
48. Spencer T., Biederman J., and Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 9 1 (2000) 77-97
49. Giros B., Jaber M., Jones S.R., et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 6566 (1996) 606-612
50. Gainetdinov R.R., Wetsel W.C., Jones S.R., et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-402
51. Cook E.H., Stein M.A., Krasowski M.D., et al. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 56 (1995) 993-998
52. Genro J.P., Zeni C., Polanczyk G.V., et al. A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. Am J Med Genet B Neuropsychiatr Genet 11 12 (2006) 1066-1067
53. Brookes K.J., Mill J., Guindalini C., et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 63 1 (2006) 74-81
54. Asherson P., Brookes K., Franke B., et al. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164 4 (2007) 674-677
55. Bakker S.C., van der Meulen E.M., Oteman N., et al. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am J Med Genet B Neuropsychiatr Genet 132 1 (2005) 50-52
56. Todd R.D. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry 31 (1992) 794-807
57. Neuman R.J., Lobos E., Reich W., et al. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 61 12 (2007) 1320-1328
58. Laucht M., Skowronek M.H., Becker K., et al. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry 64 5 (2007) 585-590
59. Comings D.E., Muhleman D., and Gysin R. Dopamine D2 receptors (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol Psychiatry 40 (1996) 368-372
60. Comings D.E., Wu H., Chiu C., et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes-DRD2, DBH and DAT1. Am J Med Genet 67 (1996) 264-288
61. Smith K.M., Daly M., Fischer M., et al. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 119B 1 (2003) 77-85
62. Daly G., Hawi Z., Fitzgerald M., et al. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4 (1999) 192-196
63. Roman T., Schmitz M., Polanczyk G.V., et al. Further evidence for the association between attention- deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 114 2 (2002) 154-158
64. Wigg K., Zai G., Schachar R., et al. Attention deficit hyperactivity disorder and the gene for dopamine Beta-hydroxylase. Am J Psychiatry 159 6 (2002) 1046-1048
65. Bhaduri N., and Mukhopadhyay K. Lack of significant association between -1021C->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci Lett 402 1-2 (2006) 12-16
66. Inkster B., Muglia P., Jain U., et al. Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder. Psychiatr Genet 14 2 (2004) 117-120
67. Payton A., Holmes J., Barrett J.H., et al. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet 105 5 (2001) 464-470
68. Hawi Z., Foley D., Kirley A., et al. Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population. Mol Psychiatry 6 4 (2001) 420-424
69. Zhang H.B., Wang Y.F., Li J., et al. [Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder]. [Chinese]. Zhonghua Er Ke Za Zhi 43 1 (2005) 26-30
70. Cases O., Lebrand C., Giros B., et al. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J Neurosci 18 17 (1998) 6914-6927
71. Manor I., Tyano S., Mel E., et al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 7 6 (2002) 626-632
72. Lawson D.C., Turic D., Langley K., et al. Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet 116B 1 (2003) 84-89
73. Das M., Das Bhowmik A., Sinha S., et al. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children. Am J Med Genet B Neuropsychiatr Genet 141B 6 (2006) 637-642
74. Jiang S., Xin R., Lin S., et al. Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am J Med Genet 105 8 (2001) 783-788
75. Domschke K., Sheehan K., Lowe N., et al. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 134B 1 (2005) 110-114
76. Xu X., Brookes K., Chen C.K., et al. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry 7 1 (2007) 10
77. Comings D.E., Comings B.G., Muhleman D., et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assoc 266 13 (1991) 1793-1800
78. Sery O., Drtilkova I., Theiner P., et al. Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett 27 1-2 (2006) 236-240
79. Kim J.W., Park C.S., Hwang J.W., et al. Clinical and genetic characteristics of Korean male alcoholics with and without attention deficit hyperactivity disorder. Alcohol Alcohol 41 4 (2006) 407-411
80. Rowe D.C., den Oord E.J., Stever C., et al. The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol Psychiatry 4 6 (1999) 580-586
81. Huang Y.S., Lin S.K., Wu Y.Y., et al. A family-based association study of attention-deficit hyperactivity disorder and dopamine D2 receptor TaqI A alleles. Chang Gung Med J 26 12 (2003) 897-903
82. Kirley A., Hawi Z., Daly G., et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27 4 (2002) 607-619
83. Barr C.L., Wigg K.G., Wu J., et al. Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 96 1 (2000) 114-117
84. Muglia P., Jain U., and Kennedy J.L. A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Behav Brain Res 130 1-2 (2002) 91-95
85. Comings D.E., Gade-Andavolu R., Gonzalez N., et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57 3 (2000) 178-196
86. Retz W., Rosler M., Supprian T., et al. Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 110 5 (2003) 561-572
87. Syvanen A.C., Tilgmann C., Rinne J., et al. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 7 1 (1997) 65-71
88. Reuter M., Kirsch P., and Hennig J. Inferring candidate genes for attention deficit hyperactivity disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS). J Neural Transm 113 7 (2006) 929-938
89. Gothelf D., Michaelovsky E., Frisch A., et al. Association of the low-activity COMT 158 Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol 10 3 (2007) 301-308
90. Brookes K.J., Knight J., Xu X., et al. DNA pooling analysis of ADHD and genes regulating vesicle release of neurotransmitters. Am J Med Genet B Neuropsychiatr Genet 139 (2005) 33-37
91. Comings D.E., Gonzalez N.S., Cheng Li S.C., et al. A "line item" approach to the identification of genes involved in polygenic behavioral disorders: the adrenergic alpha2A (ADRA2A) gene. Am J Med Genet 118B 1 (2003) 110-114
92. Xu C., Schachar R., Tannock R., et al. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 105 2 (2001) 159-162
93. Roman T., Schmitz M., Polanczyk G.V., et al. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?. Am J Med Genet 120B 1 (2003) 116-120
94. Park L., Nigg J.T., Waldman I.D., et al. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10 6 (2005) 572-580
95. Schmitz M., Denardin D., Silva T.L., et al. Association between Alpha-2a-adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry 60 10 (2006) 1028-1033
96. Stevenson J., Langley K., Pay H., et al. Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene. J Child Psychol Psychiatry 46 10 (2005) 1081-1088
97. Wang B., Wang Y., Zhou R., et al. Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 141B 2 (2006) 130-134
98. Deupree J.D., Smith S.D., Kratochvil C.J., et al. Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am J Med Genet B Neuropsychiatr Genet 141 8 (2006) 877-884
99. Roman T., Polanczyk G.V., Zeni C., et al. Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. Mol Psychiatry 11 1 (2006) 8-10
100. Waldman I.D., Nigg J.T., Gizer I.R., et al. The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn Affect Behav Neurosci 6 1 (2006) 18-30
101. Comings D., Gade-Andavolu R., Gonzalez N., et al. Additive effect of three noradenergic genes (ADRA2A, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities an Tourette syndrome subjects. Clin Genet 55 3 (1999) 160-172
102. Barr C.L., Wigg K., Zai G., et al. Attention-deficit hyperactivity disorder and the adrenergic receptors alpha1C and alpha2C. Mol Psychiatry 6 3 (2001) 334-337
103. De Luca V., Muglia P., Vincent J.B., et al. Adrenergic alpha 2C receptor genomic organization: association study in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 127B 1 (2004) 65-67
104. Biederman J., and Spencer T. Non-stimulant treatments for ADHD. Eur Child Adolesc Psychiatry 9 Suppl 1 (2000) I51-I59
105. Barr C.L., Kroft J., Feng Y., et al. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet 114 3 (2002) 255-259
106. McEvoy B., Hawi Z., Fitzgerald M., et al. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am J Med Genet 114 6 (2002) 665-666
107. Xu X., Knight J., Brookes K., et al. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. Am J Med Genet B Neuropsychiatr Genet 134B 1 (2005) 115-118
108. Bobb A.J., Addington A.M., Sidransky E., et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 134B 1 (2005) 67-72
109. Kim C.H., Hahn M.K., Joung Y., et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA 103 50 (2006) 19164-19169
110. Hawi Z., Dring M., Kirley A., et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry 7 7 (2002) 718-725
111. Quist J.F., Barr C.L., Schachar R., et al. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol Psychiatry 8 1 (2003) 98-102
112. Smoller J.W., Biederman J., Arbeitman L., et al. Association between the 5HT1B Receptor Gene (HTR1B) and the Inattentive Subtype of ADHD. Biol Psychiatry 59 5 (2006) 460-467
113. Heiser P., Dempfle A., Friedel S., et al. Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample. J Neural Transm 114 4 (2007) 513-521
114. Li J., Wang Y., Zhou R., et al. Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 132B 1 (2005) 59-63
115. Quist J.F., Barr C.L., Schachar R., et al. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5 5 (2000) 537-541
116. Zoroglu S.S., Erdal M.E., Alasehirli B., et al. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 45 4 (2002) 176-181
117. Li J., Wang Y., Zhou R., et al. No association of attention-deficit/hyperactivity disorder with genes of the serotonergic pathway in Han Chinese subjects. Neurosci Lett 403 (2006) 172-175
118. Li J., Kang C., Wang Y., et al. Contribution of 5-HT2A receptor gene -1438A > G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents. Am J Med Genet B Neuropsychiatr Genet 141B (2006) 473-476
119. Guimaraes A.P., Zeni C., Polanczyk G.V., et al. Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: preferential transmission of the HTR2A 452His allele to affected boys. Am J Med Genet B Neuropsychiatr Genet 144 1 (2007) 69-73
120. Levitan R., Masellis M., Basile V., et al. Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. J Affect Disord 71 1-3 (2002) 229-233
121. Li J., Wang Y., Zhou R., et al. Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects. Neurosci Lett 407 (2006) 107-111
122. Li J., Wang Y., Zhou R., et al. Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci Lett 401 (2006) 6-9
123. Li J., Zhang X., Wang Y., et al. The serotonin 5-HT1D receptor gene and attention-deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 141B 8 (2006) 874-876
124. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 8 6 (2003) 574-591
125. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 8 7 (2003) 646-653
126. Curran S., Purcell S., Craig I., et al. The serotonin transporter gene as a QTL for ADHD. Am J Med Genet B Neuropsychiatr Genet 134B 1 (2005) 42-47
127. Kim S.J., Badner J., Cheon K.A., et al. Family-based association study of the serotonin transporter gene polymorphisms in Korean ADHD trios. Am J Med Genet B Neuropsychiatr Genet 139 1 (2005) 14-18
128. Xu X., Mill J., Chen C.K., et al. Family-based association study of serotonin transporter gene polymorphisms in attention deficit hyperactivity disorder: no evidence for association in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet 139 1 (2005) 11-13
129. Xu M., Hu X.T., Cooper D.C., et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. [see comments]. Cell 79 6 (1994) 945-955
130. Banerjee E., Sinha S., Chatterjee A., et al. A family-based study of Indian subjects from Kolkata reveals allelic association of the serotonin transporter intron-2 (STin2) polymorphism and attention-deficit-hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 141 4 (2006) 361-366
131. Wigg K.G., Takhar A., Ickowicz A., et al. Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms. Am J Med Genet B Neuropsychiatr Genet 141B 6 (2006) 566-570
132. Li J., Wang Y., Zhou R., et al. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 144 1 (2007) 14-19
133. Manuck S.B., Flory J.D., Ferrell R.E., et al. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 45 5 (1999) 603-614
134. Tang G., Ren D., Xin R., et al. Lack of association between the tryptophan hydroxylase gene A218C polymorphism and attention-deficit hyperactivity disorder in Chinese Han population. Am J Med Genet 105 6 (2001) 485-488
135. Li J., Wang Y.F., Zhou R.L., et al. [Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder with or without learning disorder]. Zhonghua Yi Xue Za Zhi 83 24 (2003) 2114-2118
136. Li J., Wang Y., Zhou R., et al. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 141B (2006) 126-129
137. Walther D.J., Peter J.U., Bashammakh S., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 5603 (2003) 76
138. Sheehan K., Lowe N., Kirley A., et al. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 10 10 (2005) 944-949
139. Walitza S., Renner T.J., Dempfle A., et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry 10 12 (2005) 1126-1132
140. Sheehan K., Hawi Z., Gill M., et al. No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci Lett 412 2 (2007) 105-107
141. Wilson M.C. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 24 1 (2000) 51-57
142. Barr C.L., Feng Y., Wigg K., et al. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 5 4 (2000) 405-409
143. Brophy K., Hawi Z., Kirley A., et al. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry 7 8 (2002) 913-917
144. Kustanovich V., Merriman B., McGough J., et al. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol Psychiatry 8 3 (2003) 309-315
145. Mill J., Curran S., Kent L., et al. Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Genet 114 3 (2002) 269-271
146. Mill J., Richards S., Knight J., et al. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9 (2004) 801-810
147. Feng Y., Crosbie J., Wigg K., et al. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 10 11 (2005) 998-1005 973
148. Kim J.W., Biederman J., Arbeitman L., et al. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 144 (2007) 781-790
149. Comings D.E., Gade-Andavolu R., Gonzalez N., et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 58 1 (2000) 31-40
150. Kent L., Middle F., Hawi Z., et al. Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr Genet 11 1 (2001) 37-40
151. Todd R.D., Lobos E.A., Sun L.W., et al. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems. Mol Psychiatry 8 1 (2003) 103-108
152. Lee J., Laurin N., Crosbie J., et al. Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder. Genes Brain Behav (2007)
153. Turic D., Langley K., Mills S., et al. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 9 2 (2004) 169-173
154. Adams J., Crosbie J., Wigg K., et al. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry 9 5 (2004) 494-499
155. Egan M.F., Kojima M., Callicott J.H., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 2 (2003) 257-269
156. Kent L., Green E., Hawi Z., et al. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry 10 (2005) 939-943
157. Xu X., Mill J., Zhou K., et al. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet 144 1 (2007) 83-86